Preoperative assessment of factors associated with difficulty in performing total laparoscopic hysterectomy

Saito, Ako; Hirata, Tetsuya; Koga, Kaori; Takamura, Masashi; Fukuda, Seisuke; Neriishi, Kazuaki; Pastorfide, Gia; Harada, Miyuki; Hirota, Yasushi; Wada-Hiraike, Osamu; Fujii, Tomoyuki; Osuga, Yutaka

doi:10.1111/jog.13198

Cited by 24 publications

(17 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The procedure performed in five included studies was vaginal hysterectomy. 14,17,29,32,33 Ten of the remaining included studies assessed the odds of surgical complications following minimally invasive hysterectomy (laparoscopic-assisted vaginal hysterectomy, total laparoscopic hysterectomy, and roboticassisted hysterectomy) 16,[20][21][22][23]27,28,31,34,35 and 11 included studies assessed the odds of various types of hysterectomy including total abdominal hysterectomy and vaginal hysterectomy. 4,6,15,18,19,[24][25][26]30,36,37 Study designs of the included studies were cohort studies (24) 4,6,14-25,27-29,31-37 and case-control studies (two) 26,30 (Tables S3 and S4).…”

Section: Resultsmentioning

confidence: 99%

“…Quality assessment among 24 cohort studies using the Newcastle-Ottawa Scale indicated that high risks for comparability and outcome assessment were, respectively, noted in 15 [14][15][16][17][18][21][22][23][24][25]27,28,33,34,36 and 12 studies. 6,14,15,17,18,22,27,29,31,33,34,37 No cohort study was judged as having a high risk of selection bias. The two case-control studies 26,30 included in this review were determined as having low-to-moderate risks of bias for all items.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

<p>Perioperative Complications of Hysterectomy After a Previous Cesarean Section: A Systematic Review and Meta-Analysis</p>

Rattanakanokchai¹,

Kietpeerakool²,

Srisomboon³

et al. 2019

CLEP

View full text Add to dashboard Cite

Background: With increasing rates of cesarean sections (CS), the number of hysterectomies performed among women with a previous CS is on the rise. Objective: To provide the association between the odds of complications following a hysterectomy performed later in life and a previous CS. Search strategy: A comprehensive search was performed using major electronic databases, ie, MEDLINE, Scopus, ISI Web of Science, from their inception to April 2019. Selection criteria: Analytical studies, irrespective of language or publication status, were included. Data collection and analysis: Outcomes were extracted in duplicate. The methodological quality of the included studies was independently evaluated by two review authors. A threelevel meta-analysis was applied for outcomes with dependent effect sizes. Main results: Twenty-six studies were included involving 54,815 women. The odds of the following complications were increased in women with a previous CS: urinary tract injury (pooled unadjusted odds ratio (OR)=3.15, 95% CI=2.01-4.94, 15 studies, 33,902 women, and pooled adjusted OR=2.21, 95% CI=1.46-3.34, 3 studies, 31,038 women), gastrointestinal tract injury (pooled unadjusted OR=1.73, 95% CI=1.19-2.53; 7 studies, 30,050, and pooled adjusted OR=1.83, 95% CI=1.11-3.03, 1 study, 25,354 women), postoperative infections (pooled unadjusted OR=1.44, 95% CI=1.22-1.71, 6 studies, 37,832 women), wound complications (pooled unadjusted OR=2.24, 95% CI=1. 9 studies,37,559 women), reoperation (pooled unadjusted OR=1.46, 2 studies,9,899 women), and blood transfusion (pooled unadjusted OR=1.35, 95% CI=1.03-1.76, 7 studies, 13,430 women). Conclusion: Previous CS increases risks of various complications following hysterectomy. This information reminds the gynecologists to be aware of the associations between previous CS and potential complications among women undergoing hysterectomy. Prospero registration number: CRD42018085061.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

<p>Perioperative Complications of Hysterectomy After a Previous Cesarean Section: A Systematic Review and Meta-Analysis</p>

Rattanakanokchai¹,

Kietpeerakool²,

Srisomboon³

et al. 2019

CLEP

View full text Add to dashboard Cite

show abstract

“…Hence, type 2 adenomyosis may be a good therapeutic target for long‐term dienogest administration. In addition, we previously reported that type 2 adenomyosis increased the difficulty of laparoscopic hysterectomy because of severe adhesion due to pelvic endometriosis . Therefore, long‐term dienogest administration may be beneficial to avoid difficult hysterectomy for patients with type 2 adenomyosis.…”

Section: Discussionmentioning

confidence: 99%

Long‐term dienogest administration in patients with symptomatic adenomyosis

Neriishi

Hirata

Fukuda

et al. 2018

J of Obstet and Gynaecol

Self Cite

View full text Add to dashboard Cite

show abstract

“…When surgical intervention is necessary, total laparoscopic hysterectomy (TLH) is the preferred surgical treatment, and it has been found that reducing the uterine volume can expand the indications for and reduce the difficulty of TLH. [ 14 ] Therefore, preventing an increase in uterine volume should be considered as a high priority in the treatment of this condition. Previous reports have shown that GnRHa significantly reduces adenomyosis volume,[ 7 ] but there have been no definitive reports on the effects of LEP therapy on uterine volume in patients with adenomyosis.…”

Section: Discussionmentioning

confidence: 99%

Efficacy of hormonal therapies for decreasing uterine volume in patients with adenomyosis

Matsushima

Akira

Fukami

et al. 2018

Gynecol Minim Invasive Ther

View full text Add to dashboard Cite

Study objective:The aim of this study is to evaluate the efficacy of hormonal therapies for inhibiting an increase in uterine volume in patients with adenomyosis.Design:This was retrospective cohort study.Setting:This study was conducted at Nippon Medical School Musashikosugi Hospital.Patients:A total of 28 women diagnosed with adenomyosis using magnetic resonance imaging.Methods:After providing informed consent, patients were treated with gonadotropin-releasing hormone agonist (GnRHa group), a low-dose estrogen and progestin combination (LEP group), or dienogest (DNG group) for ≥16 weeks. Uterine volume was assessed using the formula for an ovoid; uterine volumes before and after 16 weeks of treatment were compared. A <5% increase in uterine volume at 16 weeks was considered to reflect inhibition of uterine volume increase and efficacy of the medication. We compared the efficacy rate among the groups.Results:In the GnRHa group, a significant reduction in uterine volume was noted, from 307.4 ± 230.1 to 177.9 ± 142.1 cm3 (P < 0.001). In the LEP and the DNG groups, there was no significant change (LEP: 226.7 ± 116.6 cm3 pre-treatment and 230.5 ± 128.6 cm3 post-treatment, P = 0.85; DNG: 232.6 ± 117.8 cm3 pre-treatment and 262.1 ± 136.8 cm3 post-treatment, P = 0.37). The number of responders (efficacy rate) in the GnRHa group, LEP group, and DNG group was 25/26 (96.2%), 7/15 (46.7%), and 6/11 (54.5%), respectively. The efficacy rate of GnRHa therapy was significantly higher than that of LEP or DNG therapy (P < 0.001 and P = 0.005, respectively).Conclusion:We conclude that the efficacy of GnRHa in reducing uterine volume should be considered when prescribing hormone therapy for adenomyosis.

show abstract

Preoperative assessment of factors associated with difficulty in performing total laparoscopic hysterectomy

Cited by 24 publications

References 30 publications

<p>Perioperative Complications of Hysterectomy After a Previous Cesarean Section: A Systematic Review and Meta-Analysis</p>

<p>Perioperative Complications of Hysterectomy After a Previous Cesarean Section: A Systematic Review and Meta-Analysis</p>

Long‐term dienogest administration in patients with symptomatic adenomyosis

Efficacy of hormonal therapies for decreasing uterine volume in patients with adenomyosis

Contact Info

Product

Resources

About